Therapeutic Potential of Myrrh and Ivermectin against Experimental Trichinella spiralis Infection in Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Trichinosis is a parasitic zoonosis caused by the nematode Trichinella spiralis. Anthelmintics are used to eliminate intestinal adults as well as tissue-migrating and encysted larvae. This study aimed to investigate the effects of ivermectin and myrrh obtained from the aloe-gum resin of Commiphora molmol on experimental trichinosis. Ninety albino mice were orally infected with 300 T. spiralis larvae. Drugs were tested against adult worms at day 0 and day 5 and against encysted larvae on day 15 and day 35 post-infection (PI). Mature worms and encysted larvae were counted in addition to histopathological examination of muscle specimens. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein, albumin, globulin, urea, and creatinine values were estimated. Significant reductions in mean worm numbers were detected in ivermectin treated mice at day 0 and day 5 PI achieving efficacies of 98.5% and 80.0%, while efficacies of myrrh in treated mice were 80.7% and 51.5%, respectively. At days 15 and 35 post-infection, ivermectin induced significant reduction in encysted larval counts achieving efficacies of 76.5% and 54.0%, respectively, while myrrh efficacies were 76.6% and 35.0%, respectively. AST, ALT, urea, and creatinine levels were reduced, while total proteins were increased in response to both treatments compared to their values in the infected non-treated mice. Ivermectin use for controlling T. spiralis could be continued. Myrrh was effective and could be a promising drug against the Egyptian strains of T. spiralis with results nearly comparable to ivermectin.
Abstract
Trichinosis is a parasitic zoonosis caused by the nematode Trichinella spiralis. Anthelmintics are used to eliminate intestinal adults as well as tissue-migrating and encysted larvae. This study aimed to investigate the effects of ivermectin and myrrh obtained from the aloe-gum resin of Commiphora molmol on experimental trichinosis. Ninety albino mice were orally infected with 300 T. spiralis larvae. Drugs were tested against adult worms at day 0 and day 5 and against encysted larvae on day 15 and day 35 post-infection (PI). Mature worms and encysted larvae were counted in addition to histopathological examination of muscle specimens. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein, albumin, globulin, urea, and creatinine values were estimated. Significant reductions in mean worm numbers were detected in ivermectin treated mice at day 0 and day 5 PI achieving efficacies of 98.5% and 80.0%, while efficacies of myrrh in treated mice were 80.7% and 51.5%, respectively. At days 15 and 35 post-infection, ivermectin induced significant reduction in encysted larval counts achieving efficacies of 76.5% and 54.0%, respectively, while myrrh efficacies were 76.6% and 35.0%, respectively. AST, ALT, urea, and creatinine levels were reduced, while total proteins were increased in response to both treatments compared to their values in the infected non-treated mice. Ivermectin use for controlling T. spiralis could be continued. Myrrh was effective and could be a promising drug against the Egyptian strains of T. spiralis with results nearly comparable to ivermectin.
참고문헌 (45)
- Murrell KD, "Trichinellosis: now and forevermore?", Parasite, 8, pp.S11~S13 (2001)
- Hosking BC, "Multigeneric resistance to oxfendazole by nematodes in cattle", Vet Rev, 138, pp.67~68 (1996)
- Teppema JS, "Ultrastructural aspects of capsule formation in Trichinella spiralis infection in the rat", Parasitology, 66, pp.291~296 (1973)
- Cabié A, "Albendazole versus thiabendazole as therapy for trichinosis: A retrospective study", Clin Infect Dis, 22, pp.1033~1035 (1996)
- Campbell WC, "Chemotherapy of Trichinella spiralis infections (a review)", Exp Parasitol, 35, pp.304~334 (1974)
- Soliman GA, "Therapeutic efficacy of dormectin, ivermectin and levamisole against different stages of Trichinella spiralis in rats", Turkiye Parazitol Derg, 35, pp.86~91 (2011)
- McCavera S, "Nematode ligand-gated chloride channels: an appraisal of their involvement in macrocyclic lactone resistance and prospects for developing molecular markers", Parasitology, 134, pp.1111~1121 (2007)
- Chippaux JP, "The use of ivermectin in control of onchocerciasis", Sante, 5, pp.149~158 (1995)
- Kamel AM, "Ivermectin and thiabendazole in experimental trichinosis", In Trichinellosis: Proceedings of the eighth international conference on trichinellosis, pp.417~ (1993)
- Ramisz A, "Efficacy of Moxidectin on experimental infection of Trichinella spiralis in mice", In Trichinellosis: Proceedings of the eighth international conference on trichinellosis, pp.449~451 (1993)
- el-Azzouni MZ, "Effect of ivermectin on experimental trichinosis", J Egypt Soc Parasitol, 27, pp.331~340 (1997)
- Freedman DO, "The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans", J Infect Dis, 159, pp.1151~1153 (1989)
- Abu El Ezz NM, "Effects of Nigella sativa and Allium cepa oils on Trichinella spiralis in experimentally infected rats", J Egypt Soc Parasitol, 35, pp.511~523 (2005)
- Atta AH, "Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts", J Ethnopharmacol, 60, pp.117~124 (1998)
- Dolara P, "Menichetti S, Lo Nostro A. Local anaesthetic and antifungal properties of sesquiterpenes from myrrh", Planta Med, 66, pp.356~358 (2000)
- Massoud A, "Therapeutic efficacy of new schistosmicidal drug derived from myrrh in active intestinal schistosomiasis complicated with hepatosplenomegaly", Proceedings of International Congress of Parasitology, pp.24~28 (1998)
- El-Gohary Y, "Pilot study on a new fasciolicidal drug (Myrrh)", Alex Med J, 14, pp.12~27 (1999)
- Massoud AM, "Laboratory studies on the molluscicidal and cercaricidal activities of Commiphora molmol", Egypt J Aquat Biol Fish, 4, pp.251~266 (2000)
- Sheir Z, "A safe, effective herbal anti-schistosomal therapy derived from myrrh", Am J Trop Med Hyg, 65, pp.700~704 (2001)
- Guenther S, "pseudospiralis in muscle tissue with real-time PCR", J Microbiol Methods, 75, pp.287~292 (2008)
- Coulaud JP, "Ivermectin in onchocerciasis", Lancet, 2, pp.526~527 (1984)
- Massoud A, "Treatment of Egyptian dicrocoeliasis in man and animals with Mirazid", J Egypt Soc Parasitol, 33, pp.437~442 (2003)
- Denham DA, "Studies with methyridine and Trichinella spiralis. I. Effect upon the intestinal phase in mice", Exp Parasitol, 17, pp.10~14 (1965)
- Carleton MA, "Carleton,s histological technique" (1967), Oxford Univ Press
- Hosking BC, "Multigeneric resistance to oxfendazole by nematodes in cattle", Vet Rec, 138, pp.67~68 (1996)
- Gamble HR, "Diagnosis of trichinellosis in swine by enzyme immunoassay, using a synthetic glycan antigen", Am J Vet Res R, 58, pp.1417~1421 (1997)
- Wu Z, "Trichinella spiralis: nurse cell formation with emphasis on analogy to muscle cell repair", Parasit Vectors, 1, pp.27~ (2008)
- Gagliardo LF, "Molting, ecdysis, and reproduction of Trichinella spiralis are supported in-vitro by intestinal epithelial cells", Infect Immun, 70, pp.1853~1859 (2002)
- Pozio E, "Hosts and habitats of Trichinella spiralis and Trichinella britovi in Europe", Int J Parasitol, 39, pp.71~79 (2009)
- Gottstein B, "Epidemiology, diagnosis, treatment, and control of trichinellosis", Clin Microbiol Rev, 22, pp.127~145 (2009)
- Kociecka W, "Trichinellosis: human disease, diagnosis and treatment", Vet Parasitol, 93, pp.365~383 (2000)
- Siriyasatien P, "Effects of albendazole against early and late stages of Trichinella spiralis infection in mice", J Med Assoc Thai, 86, pp.S257~S262 (2003)
- Casulli A, "2-Hy droxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model", J Antimicrob Chemother, 58, pp.886~890 (2006)
- Despommier DD, "Biology of Trichinella and trichinosis, In Trichinella and trichinosis", pp.42~75 (1983), Plenum Press
- Omar M, "Effects of synanthic and ivomec on with reference to their serological evaluation", Vet Med J, 43, pp.31~35 (1995)
- Song-Mingxin L, "Efficacy of ivermectin and albendazole against the various phases of 4 Trichinella isolates in treating mice", Chin J Zoon, 18, pp.89~91 (2002)
- Barton NJ, "The therapeutic efficacy and prophylactic activity of dormectin against Dictyocaulus vivparus in cattles", Aust Vet J, 72, pp.349~351 (1995)
- Ros-Moreno RM, "Rodríguez-Caabeiro F. Interactions of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae", Parasitol Res, 85, pp.320~323 (1999)
- Whealton A, "Colorimetric Determination of serum urea concentration, In Tietz Textbook of Clinical Chemistry", pp.1528~1531 (1994), Saunders
- Arise RO, "Effects of ivermectin and albendazole on some liver and kidney function indices in rats", Afr J Biochem Res, 3, pp.190~197 (2009)
- Kimura I, "New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice", Bioorg Med Chem Lett, 11, pp.985~989 (2001)
- Al-Mathal EM, "Efficacy of Commiphora molmol against hepatic coccidiosis (Eimeria stiedae) in the domestic rabbit", J Food Agric Environ, 8, pp.1072~1080 (2010)
- Massoud A, "Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh)", Am J Trop Med Hyg, 65, pp.96~99 (2001)
- Wolstenholme AJ, "Drug resistance in veterinary helminthes", Trends Parasitol, 20, pp.469~476 (2004)
- Osei-Atweneboana MY, "Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study", Lancet, 369, pp.2021~2029 (2007)